Department of Pharmacology, Toxicology and Neuroscience, LSU Health Sciences Center, Shreveport, LA, USA.
Clin Toxicol (Phila). 2022 Mar;60(3):324-331. doi: 10.1080/15563650.2021.1953049. Epub 2021 Jul 19.
Diethylene glycol (DEG) is an organic compound found in household products but also as a counterfeit solvent in medicines. DEG poisonings are characterized by acute kidney injury (AKI) and by neurological sequelae such as decreased reflexes or face and limb weakness. Previous studies in male rats have demonstrated that neurotoxic effects develop only with the establishment of AKI, but the dose sensitivity of females to DEG toxicity is unknown.
Assessing whether subacute administration of DEG in female rats would delineate any sex-differences in neuropathy or in kidney injury.
Female Wistar-Han rats were orally administered doses of 4 - 6 g/kg DEG every 12 h and monitored for 7 days. Urine was collected every 12 h and endpoint blood and cerebrospinal fluid (CSF) were collected for renal plasma parameters and total protein estimation, respectively. Motor function tests were conducted before and after treatment. Kidney and brain tissue were analyzed for metabolite content.
Of 12 animals treated with DEG, 3 developed AKI as confirmed by increased BUN and creatinine concentrations. Renal and brain DGA contents were increased in animals that developed AKI compared to animals without AKI. Total CSF protein content in animals with AKI was markedly elevated compared to control and to treated animals without AKI. Decreases in forelimb grip strength and in locomotor and rearing activity were observed in animals with AKI compared to control and to animals without AKI.
Repeated dosing with DEG in a female model produced nephrotoxic effects at a dose similar to that in males. The decrease in motor function and increase in CSF protein were only present in females that developed AKI. However, kidney and neurologic effects were assessed only at the end of the treatments, thus limiting determination of which effect occurs first. Limb function and coordination were measured globally and more sensitive tests such as nerve conduction studies might offer a detailed neurotoxicity assessment of the effects of DEG.
These studies show that DEG toxicity does not appear to be sex-specific and that, in males and females, neurological symptoms are present only when DGA accumulation and kidney injury also occur.
二甘醇(DEG)是一种存在于家用产品中的有机化合物,但也被用作药品中的假冒溶剂。DEG 中毒的特征是急性肾损伤(AKI)和反射减弱或面部和四肢无力等神经后遗症。先前在雄性大鼠中的研究表明,神经毒性作用仅在 AKI 确立后才会出现,但雌性对 DEG 毒性的剂量敏感性尚不清楚。
评估亚急性 DEG 给药是否会在女性大鼠中描绘出神经病或肾损伤方面的任何性别差异。
雌性 Wistar-Han 大鼠经口给予 4-6 g/kg DEG,每 12 小时一次,并监测 7 天。每隔 12 小时收集尿液,并在治疗前后分别采集终点血液和脑脊液(CSF)以估计肾血浆参数和总蛋白。进行运动功能测试。分析肾脏和脑组织中的代谢物含量。
在接受 DEG 治疗的 12 只动物中,有 3 只动物因 BUN 和肌酐浓度升高而被确认为 AKI。与未发生 AKI 的动物相比,发生 AKI 的动物的肾脏和大脑 DGA 含量增加。与对照和未发生 AKI 的治疗动物相比,发生 AKI 的动物的总 CSF 蛋白含量明显升高。与对照和未发生 AKI 的动物相比,发生 AKI 的动物的前肢握力以及运动和后肢支撑活动减少。
在雌性模型中重复给予 DEG 剂量会产生类似于雄性的肾毒性作用。仅在发生 AKI 的雌性动物中观察到运动功能下降和 CSF 蛋白增加。然而,仅在治疗结束时评估肾脏和神经效应,因此限制了确定哪个效应首先发生。肢体功能和协调性是全身性测量的,更敏感的测试(如神经传导研究)可能会提供对 DEG 影响的详细神经毒性评估。
这些研究表明,DEG 毒性似乎不是性别特异性的,并且在男性和女性中,只有当 DGA 积累和肾损伤也发生时才会出现神经症状。